CD177 and cancer: Interestingly, it has been suggested that EGCG can bind to lipid raft-associated cell surface receptor (e.g., the 67 kDa laminin receptor, 67LR) to confer its anti-cancer properties [42], [43], or anti-inflammatory allergic response [44], [45].